Bedrocan Receives Health Canada Approval to Sell Domestically Produced Medical Cannabis

Health Canada Also Approves 8 More Growing Rooms

Immediate Increase in Product Revenue

TORONTO, July 28, 2015 /CNW/ - Bedrocan Cannabis Corp. (TSXV: BED) ("the Company" or "Bedrocan") announced today that it has received a license amendment from Health Canada allowing for the sale of the Company's domestically produced medical cannabis. Bedrocan has been growing six proprietary genetic strains of standardized cannabis at its new production facility since February, and eight harvests have been completed successfully to date. The Company can begin immediately taking orders for sales of its existing inventory.

In addition, Health Canada has also approved eight more growing rooms at Bedrocan's production facility in theGreater Toronto Area. A total of 26 of 34 production rooms are now licensed, providing for production capacity of 3,000 kilograms per year.

"We are excited to be able to provide Canadian-grown, standardized cannabis to our registered patients," said Marc Wayne, President and CEO. "We have...

Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.


URL: 
http://article.wn.com/view/2015/07/28/Bedrocan_Receives_Health_Canada_Approval_to_Sell_Domesticall_h/